Larazotide 25 mg × 1 Vial
Batch-tested · Switzerland
Peptide · Single vial

Larazotide 25 mg × 1 vial.

Larazotide (AT-1001) is a synthetic eight-amino-acid peptide that acts on tight junctions, the seals between cells in the gut lining.

Strength
25 mg / vial
Pack
1 vial
Format
Freeze-dried
Research area
Tissue repair

Have this box? Check it's genuine.

Type the six digits from the label.

Have this box? Check it's genuine.

For laboratory research use only. Not for human consumption.

Reference profile
Reference profile

What it is.

Larazotide (AT-1001) is a synthetic eight-amino-acid peptide that acts on tight junctions, the seals between cells in the gut lining. It is designed to stop those junctions opening too far.

Key facts
  • Tight-junction regulator
  • Octapeptide
  • Zonulin antagonist

How it is used.

Larazotide is studied in gut barrier research. Studies look at intestinal permeability, tight-junction signalling and gluten-triggered inflammation in coeliac models.

Studied in
  • Gut barrier research
  • Intestinal permeability
  • Coeliac models
Quality

Tested before it's boxed.

Every batch is made in-house in Switzerland and tested for identity, purity and sterility before it is packed.

How we test
Every batch is tested for
  • Identity LC-MS
  • Content HPLC-UV
  • Purity HPLC-UV
  • Sterility USP <71>
  • Endotoxins USP <85>
  • Particulates USP <788>